ロード中...
Apatinib as an alternative therapy for advanced hepatocellular carcinoma
Angiogenesis plays an important role in the occurrence and development of tumors. Registered tyrosine kinase inhibitors targeting vascular endothelial growth factor reduce angiogenesis. Apatinib, a tyrosine kinase inhibitor, can specifically inhibit vascular endothelial growth factor receptor 2, sho...
保存先:
| 出版年: | World J Hepatol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Baishideng Publishing Group Inc
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7643208/ https://ncbi.nlm.nih.gov/pubmed/33200015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v12.i10.766 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|